ProShares Ultra Nasdaq Biotechnology (BIB) Trading Down 7.2%

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)’s share price dropped 7.2% on Monday . The company traded as low as $44.62 and last traded at $45.00. Approximately 931,219 shares were traded during trading, an increase of 345% from the average daily volume of 209,330 shares. The stock had previously closed at $48.51.

A number of large investors have recently modified their holdings of the business. Virtu Financial LLC purchased a new position in shares of ProShares Ultra Nasdaq Biotechnology in the 4th quarter worth about $1,521,000. Bell Rock Capital LLC raised its position in shares of ProShares Ultra Nasdaq Biotechnology by 32.4% in the 4th quarter. Bell Rock Capital LLC now owns 16,455 shares of the exchange traded fund’s stock worth $691,000 after purchasing an additional 4,030 shares during the last quarter. Sheaff Brock Investment Advisors LLC raised its position in shares of ProShares Ultra Nasdaq Biotechnology by 50.0% in the 4th quarter. Sheaff Brock Investment Advisors LLC now owns 15,000 shares of the exchange traded fund’s stock worth $631,000 after purchasing an additional 5,000 shares during the last quarter. Phocas Financial Corp. purchased a new position in shares of ProShares Ultra Nasdaq Biotechnology in the 4th quarter worth about $62,000. Finally, Truvestments Capital LLC purchased a new position in shares of ProShares Ultra Nasdaq Biotechnology in the 1st quarter worth about $42,000.

COPYRIGHT VIOLATION WARNING: This report was originally published by Dakota Financial News and is the property of of Dakota Financial News. If you are viewing this report on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this report can be viewed at https://dakotafinancialnews.com/2019/05/16/proshares-ultra-nasdaq-biotechnology-bib-trading-down-7-2.html.

ProShares Ultra Nasdaq Biotechnology Company Profile (NASDAQ:BIB)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.

Further Reading: Quiet Period Expirations

Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.